Jupiter Neurosciences, Inc.
JUNSNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $1.44M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.31$39.74
- Volume (live)
- -
- Avg. volume (3M)
- 71.98K
Jupiter Neurosciences (JUNS) Stock Price & Financial Analysis
Jupiter Neurosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.55 - $2.80 |
|---|---|
| 52-Week High | $39.74 |
| 52-Week Low | $0.31 |
| Open | $2.80 |
| Volume (last close) | 10.14K |
| Average Volume (3M) | 71.98K |
| Revenue (TTM) | 64.69K |
|---|---|
| Net Income (TTM) | -9.20M |
| Free Cash Flow (TTM) | -7.25M |
| EPS (TTM) | −$18.96 |
| Profit Margin | -14220.12% |
| Operating Margin | -15166.68% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.44M |
|---|---|
| Shares Outstanding | 557.57K |
| Price to Sales (P/S) | 22.24 |
| Price to Book (P/B) | -3.93 |
| EV/EBITDA | -0.19 |
| 50-Day MA | $3.56 |
|---|---|
| 200-Day MA | $6.48 |
| 1-Year Change | +74.32% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Jupiter Neurosciences at a Glance
As of the Oct 22, 2026 close, Jupiter Neurosciences (JUNS) has a market capitalization of $1.44M. The stock trades at 22.2× sales. Over the trailing twelve months it lost $9.20M on revenue of $64.69K and burned $7.25M of free cash flow.
As of its latest reported balance sheet, it holds $1.52M in cash and securities against $1.75M of debt, a net debt position of $227.20K.
Jupiter Neurosciences does not currently pay a dividend.
The share price is up 74.3% over the past year. At $2.58 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.31 to $39.73, below its 200-day moving average of $6.48.
Frequently Asked Questions About Jupiter Neurosciences
What is the current stock price for JUNS?
As of the Oct 22, 2026 close, JUNS stock trades at $2.58. The 52-week range is $0.31–$39.74, with a day range of $2.55–$2.80.
What is the P/E ratio for JUNS?
The P/E ratio (Price-to-Earnings) for JUNS is shown in the Key Statistics section. This valuation metric helps compare Jupiter Neurosciences, Inc. to industry peers.
Does JUNS pay dividends?
Jupiter Neurosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for JUNS?
Analyst ratings and recommendations for JUNS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of JUNS?
As of the Oct 22, 2026 close, Jupiter Neurosciences's market capitalization is $1.4M, classifying it as a micro-cap company. Jupiter Neurosciences operates in the Healthcare sector within the Biotechnology industry.